Pharma Glycovax Inc: federal grants and contributions: 3 agreements; $8.8M value; 2 departments; 2 programs.
Assay record ASY-CA-1ELBXCL1G8 · Cite as: Assay Systems, “Pharma Glycovax Inc: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/pharma-glycovax-inc/
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinical level (phase I).
Marketing strategy: The project aims to market the products of a company specialized in the development of molecules used in the manufacturing of vaccines and medical treatments.
ARP - Development of rabbit antibodies for the detection of human cancer
All grants from Canada Economic Development for Quebec Regions
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.